➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Johnson and Johnson
Dow
Moodys
Merck

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

VITRASE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for VITRASE

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Bausch & Lomb IncorporatedPhase 2
Bausch & Lomb IncorporatedPhase 3
Bausch & Lomb IncorporatedPhase 4

See all VITRASE clinical trials

Recent Litigation for VITRASE

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC2018-11-09
Halozyme, Inc. v. Lee2016-12-19
PIECZENIK v. BAYER CORPORATION2010-05-04

See all VITRASE litigation

PTAB Litigation
PetitionerDate
2017-05-30
2017-01-31

See all VITRASE litigation

Patent Text Search: US Patents for VITRASE

These patents were identified by searching patent claims

Supplementary Protection Certificates for VITRASE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
92273 Luxembourg   Start Trial PRODUCT NAME: MICROPLASMIN
163 8-2013 Slovakia   Start Trial PRODUCT NAME: OKRIPLAZMIN; REGISTRATION NO/DATE: EU/1/13/819/001 20130313
PA2013020 Lithuania   Start Trial PRODUCT NAME: OCRIPLASMINUM (MICROPLASMINUM); REGISTRATION NO/DATE: EU/1/13/819/001 20130313
300822 Netherlands   Start Trial PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
92780 Luxembourg   Start Trial PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Dow
Express Scripts
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.